sofidexFor patientsAre you a clinician? Clinical site

Health Library  ›  News  ›  Health notices · Monday 17 August

Updates ·

Health notices · Monday 17 August

3 notices from the agencies today, in plain words, each with the original linked.

About 1 minute to readNoticePublished August 2026

PDF
a plain paper envelope and an unopened cardboard box on a table

Oma's Pride recalls Woof Complete Canine Chicken Recipe due to possible Salmonella

CDC · Food safety

If you have a dog and bought Woof Complete Canine Chicken Recipe (6 lb bag), a Centers for Disease Control and Prevention notice says one lot may be contaminated with Salmonella.

Salmonella is a germ that can make people sick after contact with contaminated food, including through handling pet food or bowls.

Check whether your bag matches the recalled lot; avoid contact with the contents and follow the recall actions listed by the company or seller.

What to do

  • Use the company’s or seller’s recall instructions for the recalled lot (Lot BB012729).

Read the original notice

FDA approval of sitagliptin phosphate for type 2 diabetes

FDA · Approval

If you have type 2 diabetes, the US Food and Drug Administration has approved sitagliptin phosphate (an oral tablet) as an add-on to diet and exercise to improve glycemic control.

Sitagliptin is a DPP-4 inhibitor, a type of medicine used to help lower blood sugar. It should not be used for type 1 diabetes.

The label also notes it has not been studied in people with a history of pancreatitis, and it is unknown whether that history increases risk while using sitagliptin.

Read the original notice

FDA approves first oral PCSK9 inhibitor for high LDL cholesterol

FDA · Announcement

If you are an adult with high cholesterol, the FDA has approved Lipfendra (enlicitide) as an add-on to diet and exercise to reduce low-density lipoprotein cholesterol (LDL-C), often called “bad” cholesterol.

PCSK9 is a protein involved in LDL-C levels. This medicine is a PCSK9 inhibitor, designed to lower LDL-C.

This means that, tomorrow, your treatment options for lowering LDL-C may include a first oral option that can be used along with diet and exercise.

Read the original notice